Tag Archives: Teva

Teva, Endo among generics paying $70M in California pay-for-delay settlement

Dive Brief: Three generics makers will pay California almost $ 70 million collectively to resolve allegations they engaged in pay-for-delay deals with branded drug companies, in turn driving healthcare costs higher for consumers. One allegation targeted Israeli drug giant Teva for the monopoly it held over a sleep medicine called Provigil from 2006 to 2012.… Read More »